500 members is a significant milestone in the development of RareCan.  A large number of these members have joined us through the fantastic partnership we have with GIST Cancer UK and we are now just about to embark on our first research project with Teeside University and Newcastle and Cambridge NHS Trusts.  

Early in 2022, we will continue to develop our partnership with Blood Cancer UK and continues to grow our membership throughout the year.